| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Faculté de Pharmacie, Institut National de la Santé et de la Recherche Médicale, Rennes, France; and
Faculté de Médecine, Laboratoire Universitaire d’Hématologie et de la Biologie des Cellules Sanguines, Rennes, France
Polycyclic aromatic hydrocarbons (PAHs) such as benzo(a)pyrene (BP) are ubiquitous environmental carcinogenic contaminants exerting deleterious effects toward cells acting in the immune defense such as monocytic cells. To investigate the cellular basis involved, we have examined the consequences of PAH exposure on macrophagic differentiation of human blood monocytes. Treatment by BP markedly inhibited the formation of adherent macrophagic cells deriving from monocytes upon the action of either GM-CSF or M-CSF. Moreover, it reduced expression of macrophagic phenotypic markers such as CD71 and CD64 in GM-CSF-treated monocytic cells, without altering cell viability or inducing an apoptotic process. Exposure to BP also strongly altered functional properties characterizing macrophagic cells such as endocytosis, phagocytosis, LPS-triggered production of TNF-
and stimulation of allogeneic lymphocyte proliferation. Moreover, formation of adherent macrophagic cells was decreased in response to PAHs distinct from BP such as dimethylbenz(a)anthracene and 3-methylcholanthrene, which interact, like BP, with the arylhydrocarbon receptor (AhR) known to mediate many PAH effects. In contrast, benzo(e)pyrene, a PAH not activating AhR, had no effect. In addition, AhR was demonstrated to be present and functional in cultured monocytic cells, and the use of its antagonist -naphtoflavone counteracted inhibitory effects of BP toward macrophagic differentiation. Overall, these data demonstrate that exposure to PAHs inhibits functional in vitro differentiation of blood monocytes into macrophages, likely through an AhR-dependent mechanism. Such an effect may contribute to the immunotoxicity of these environmental carcinogens owing to the crucial role played by macrophages in the immune defense.
This article has been cited by other articles:
|
|
 |
|
  A. Nakayama, I. Riesen, B. Kollner, E. Eppler, and H. Segner Surface Marker-Defined Head Kidney Granulocytes and B Lymphocytes of Rainbow Trout Express Benzo[a]pyrene-Inducible Cytochrome P4501A Protein Toxicol. Sci., May 1, 2008; 103(1): 86 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Monteiro, D. Gilot, E. Le Ferrec, C. Rauch, D. Lagadic-Gossmann, and O. Fardel Dioxin-Mediated Up-Regulation of Aryl Hydrocarbon Receptor Target Genes Is Dependent on the Calcium/Calmodulin/CaMKI{alpha} Pathway Mol. Pharmacol., March 1, 2008; 73(3): 769 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Z. Shi, N. G. Faith, Y. Nakayama, M. Suresh, H. Steinberg, and C. J. Czuprynski The Aryl Hydrocarbon Receptor Is Required for Optimal Resistance to Listeria monocytogenes Infection in Mice J. Immunol., November 15, 2007; 179(10): 6952 - 6962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lemarie, C. Morzadec, E. Bourdonnay, O. Fardel, and L. Vernhet Human macrophages constitute targets for immunotoxic inorganic arsenic. J. Immunol., September 1, 2006; 177(5): 3019 - 3027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N'Diaye, E. Le Ferrec, D. Lagadic-Gossmann, S. Corre, D. Gilot, V. Lecureur, P. Monteiro, C. Rauch, M.-D. Galibert, and O. Fardel Aryl Hydrocarbon Receptor- and Calcium-dependent Induction of the Chemokine CCL1 by the Environmental Contaminant Benzo[a]pyrene J. Biol. Chem., July 21, 2006; 281(29): 19906 - 19915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sparfel, J. Van Grevenynghe, M. Le Vee, C. Aninat, and O. Fardel Potent inhibition of carcinogen-bioactivating cytochrome P450 1B1 by the p53 inhibitor pifithrin {alpha} Carcinogenesis, March 1, 2006; 27(3): 656 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lemarie, C. Morzadec, D. Merino, O. Micheau, O. Fardel, and L. Vernhet Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic Differentiation through Nuclear Factor-{kappa}B-Related Survival Pathway Down-Regulation J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 304 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tochigi, N. Yamashiki, S. Ohgiya, S. Ganaha, and H. Yokota ISOFORM-SPECIFIC EXPRESSION AND INDUCTION OF UDP-GLUCURONOSYLTRANSFERASE IN IMMUNOACTIVATED PERITONEAL MACROPHAGES OF THE RAT Drug Metab. Dispos., September 1, 2005; 33(9): 1391 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. van Grevenynghe, M. Bernard, S. Langouet, C. Le Berre, T. Fest, and O. Fardel Human CD34-Positive Hematopoietic Stem Cells Constitute Targets for Carcinogenic Polycyclic Aromatic Hydrocarbons J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 693 - 702. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
